Patent №
US 9,732,128
Granted
2017-08-15
Filed 2011
Owner
BIOTIME, INC.
+1 more
Lab
—
AI components
1
hardware
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
13279123
The vast differentiation potential of human embryonic and induced pluripotent stem cells, including their potential to cascade through all of the somatic cell lineages and to display the complete transcriptional regulatory network of human biology, has generated interest in deriving scalable, purified, and identified cell types and methods of discovering the precise structure of the human regulatory network. However, the innate capacity of pluripotent cells to display all these lineages is not necessarily reflected during their culture in vitro. The clonal isolation and propagation of progenitors greatly facilitates the generation of highly purified and identified formulations for research and therapeutic purposes. Nevertheless, other cell types have yet to be isolated and propagated from normal cells and methods of isolating said novel cell types as well as methods for introducing perturbations into the transcriptional regulatory network in order to construct a computer model of the entire human transcriptional regulatory network would greatly benefit basic research as well as manufacturing technology for cell-based therapies.
AI classification
Ownership
BIOTIME, INC.
assignment · 277780195
LINEAGE CELL THERAPEUTICS, INC.
namechg · 531970627
Assignors
WEST, MICHAEL D., CHAPMAN, KAREN B.
On an employer assignment, the assignors are typically the inventors.